Oncotelic Therapeutics, Inc. (OTLC)
CIK 908259 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Oncotelic Therapeutics, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Aug 13, 2026 | 10-Q | 0001493152-26-037857 |
| Aug 4, 2026 | 8-K | 0001493152-26-035999 |
| Jul 23, 2026 | 4 | 0001493152-26-034397 |
| Jul 22, 2026 | D | 0001493152-26-034225 |
| Jul 21, 2026 | 4 | 0001493152-26-034069 |
| Jul 14, 2026 | 4 | 0001493152-26-033169 |
| Jul 14, 2026 | 8-K | 0001493152-26-033172 |
| Jul 14, 2026 | 4 | 0001493152-26-033166 |
| Jul 14, 2026 | 8-K | 0001493152-26-033171 |
| Jul 14, 2026 | 4 | 0001493152-26-033168 |
| Jul 14, 2026 | 4 | 0001493152-26-033167 |
| Jul 2, 2026 | 4 | 0001493152-26-031846 |
| Jun 29, 2026 | 8-K | 0001493152-26-031124 |
| Jun 24, 2026 | 4 | 0001493152-26-029997 |
| Jun 22, 2026 | 4 | 0001493152-26-029594 |
| Jun 17, 2026 | 4 | 0001493152-26-029137 |
| May 14, 2026 | 10-Q | 0001493152-26-023181 |
| May 5, 2026 | 8-K | 0001493152-26-021306 |
| Apr 16, 2026 | 8-K | 0001493152-26-016981 |
| Apr 15, 2026 | 10-K | 0001493152-26-016838 |
| Apr 2, 2026 | 8-K | 0001493152-26-014831 |
| Mar 31, 2026 | NT 10-K | 0001493152-26-014324 |
| Mar 30, 2026 | 8-K | 0001493152-26-013503 |
| Mar 30, 2026 | 8-K | 0001493152-26-013391 |
| Jan 29, 2026 | 8-K | 0001493152-26-004237 |